Tara G Edmonds
Overview
Explore the profile of Tara G Edmonds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edmonds T, Galin F, Grabowski C
Med Sci Educ
. 2024 Jan;
33(6):1465-1471.
PMID: 38188385
Medical students are the future of academic medicine. They will serve as admissions committee members, deans, and program directors with responsibility for selecting future physicians. At the same time, schools...
2.
Alberti M, Jones J, Miglietta R, Ding H, Bakshi R, Edmonds T, et al.
AIDS Res Hum Retroviruses
. 2015 Jun;
31(12):1278-96.
PMID: 26101895
We previously developed replication-competent reporter HIV-1 (referred to herein as LucR.T2A reporter viruses), utilizing a "ribosome skipping" T2A peptide strategy to link Renilla luciferase (LucR) with Nef expression. The demonstrated...
3.
Naarding M, Fernandez N, Kappes J, Hayes P, Ahmed T, Icyuz M, et al.
J Immunol Methods
. 2013 Dec;
409:161-73.
PMID: 24291126
Emergence of SIV and HIV specific CD8 T cells has been shown to correlate with control of in vivo replication. Poor correlation between IFN-γ ELISPOT responses and in vivo control...
4.
Ochsenbauer C, Edmonds T, Ding H, Keele B, Decker J, Salazar M, et al.
J Virol
. 2011 Dec;
86(5):2715-28.
PMID: 22190722
Genome sequences of transmitted/founder (T/F) HIV-1 have been inferred by analyzing single genome amplicons of acute infection plasma viral RNA in the context of a mathematical model of random virus...
5.
Edmonds T, Ding H, Yuan X, Wei Q, Smith K, Conway J, et al.
Virology
. 2010 Sep;
408(1):1-13.
PMID: 20863545
Effective vaccine development for human immunodeficiency virus type 1 (HIV-1) will require assays that ascertain the capacity of vaccine immunogens to elicit neutralizing antibodies (NAb) to diverse HIV-1 strains. To...
6.
Moody M, Liao H, Alam S, Scearce R, Plonk M, Kozink D, et al.
J Exp Med
. 2010 Apr;
207(4):763-76.
PMID: 20368576
Traditional antibody-mediated neutralization of HIV-1 infection is thought to result from the binding of antibodies to virions, thus preventing virus entry. However, antibodies that broadly neutralize HIV-1 are rare and...
7.
Geonnotti A, Bilska M, Yuan X, Ochsenbauer C, Edmonds T, Kappes J, et al.
AIDS Res Hum Retroviruses
. 2010 Mar;
26(3):279-91.
PMID: 20218881
Bacterial lipopolysaccharide (endotoxin) is a frequent contaminant of biological specimens and is also known to be a potent inducer of beta-chemokines and other soluble factors that inhibit HIV-1 infection in...
8.
Freel S, Lamoreaux L, Chattopadhyay P, Saunders K, Zarkowsky D, Overman R, et al.
J Virol
. 2010 Mar;
84(10):4998-5006.
PMID: 20200250
Control of HIV-1 replication following nonsterilizing HIV-1 vaccination could be achieved by vaccine-elicited CD8(+) T-cell-mediated antiviral activity. To date, neither the functional nor the phenotypic profiles of CD8(+) T cells...